Terms: = Liver cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
95 results:
1. First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R; Piérola AA; Donnellan WB; Yordi AM; Abdul-Hay M; Platzbecker U; Subklewe M; Kadia TM; Alonso-Domínguez JM; McCloskey J; Bradford K; Curtis M; Daskalakis N; Guttke C; Safer K; Hiebert B; Murphy J; Li X; Duchin K; Esteban D
Clin Transl Sci; 2024 Mar; 17(3):e13742. PubMed ID: 38494922
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of proton stopping power ratios using dual-energy CT basis material decomposition.
Pettersson E; Thilander-Klang A; Bäck A
Med Phys; 2024 Feb; 51(2):881-897. PubMed ID: 38194501
[TBL] [Abstract] [Full Text] [Related]
3. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.
Sarfraz M; Aziz M; Afzal S; Channar PA; Alsfouk BA; Kandhro GA; Hassan S; Sultan A; Hamad A; Arafat M; Qaiser MN; Ahmed A; Siddique F; Ejaz SA
Protein J; 2024 Apr; 43(2):207-224. PubMed ID: 37940790
[TBL] [Abstract] [Full Text] [Related]
4. Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data.
Bosi A; Barcellini W; Passamonti F; Fattizzo B
Blood Rev; 2023 Nov; 62():101132. PubMed ID: 37709654
[TBL] [Abstract] [Full Text] [Related]
5. Cytidine deaminase status as a marker of response to azacytidine treatment in mds and AML patients.
Donnette M; Hamimed M; Ciccolini J; Sicard G; Correard F; Farnault L; Ouafik L; Venton G; Fanciullino R
Br J Haematol; 2023 Nov; 203(4):625-636. PubMed ID: 37691342
[TBL] [Abstract] [Full Text] [Related]
6. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
7. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
[TBL] [Abstract] [Full Text] [Related]
8. Determination of 5-azacitidine in human plasma by LC-MS/MS: application to pharmacokinetics pilot study in mds/AML patients.
Donnette M; Osanno L; Giocanti M; Venton G; Farnault L; Berda-Haddad Y; Costello R; Caroline S; Ouafik L'; Ciccolini J; Fanciullino R
Cancer Chemother Pharmacol; 2023 Mar; 91(3):231-238. PubMed ID: 36859512
[TBL] [Abstract] [Full Text] [Related]
9. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
[TBL] [Abstract] [Full Text] [Related]
10. Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk mds and AML is feasible, safe, and active.
Garcia JS; Kim HT; Murdock HM; Cutler CS; Brock J; Gooptu M; Ho VT; Koreth J; Nikiforow S; Romee R; Shapiro R; Loschi F; Ryan J; Fell G; Karp HQ; Lucas F; Kim AS; Potter D; Mashaka T; Stone RM; DeAngelo DJ; Letai A; Lindsley RC; Soiffer RJ; Antin JH
Blood Adv; 2021 Dec; 5(24):5536-5545. PubMed ID: 34614506
[TBL] [Abstract] [Full Text] [Related]
11. Systematic review and meta-analysis of the efficacy of prophylactic abdominal drainage in major liver resections.
Dezfouli SA; Ünal UK; Ghamarnejad O; Khajeh E; Ali-Hasan-Al-Saegh S; Ramouz A; Salehpour R; Golriz M; Chang DH; Mieth M; Hoffmann K; Probst P; Mehrabi A
Sci Rep; 2021 Feb; 11(1):3095. PubMed ID: 33542274
[TBL] [Abstract] [Full Text] [Related]
12. Sclerosing Extramedullary Hematopoietic Tumor: A Case Report.
Wang D; Castro E; Rao A; McPhaul CM
J Investig Med High Impact Case Rep; 2020; 8():2324709620956463. PubMed ID: 32911987
[TBL] [Abstract] [Full Text] [Related]
13. [Cell morphological analysis of hepatosplenic T-cell lymphoma gamma-delta type].
Wu P; Sun HP; Wan LJ; Zhou CY; Wang T; Liu HX; Wang H
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(23):1805-1811. PubMed ID: 32536127
[No Abstract] [Full Text] [Related]
14. Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Bose P; McCue D; Wurster S; Wiederhold NP; Konopleva M; Kadia TM; Borthakur G; Ravandi F; Masarova L; Takahashi K; Estrov Z; Yilmaz M; Daver N; Pemmaraju N; Naqvi K; Rausch CR; Marx KR; Qiao W; Huang X; Bivins CA; Pierce SA; Kantarjian HM; Kontoyiannis DP
Clin Infect Dis; 2021 May; 72(10):1755-1763. PubMed ID: 32236406
[TBL] [Abstract] [Full Text] [Related]
15. Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.
Ramsey HE; Oganesian A; Gorska AE; Fuller L; Arrate M; Boyd K; Keer H; Azab M; Savona MR
Target Oncol; 2020 Apr; 15(2):231-240. PubMed ID: 32222953
[TBL] [Abstract] [Full Text] [Related]
16. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial.
Angelucci E; Li J; Greenberg P; Wu D; Hou M; Montano Figueroa EH; Rodriguez MG; Dong X; Ghosh J; Izquierdo M; Garcia-Manero G;
Ann Intern Med; 2020 Apr; 172(8):513-522. PubMed ID: 32203980
[TBL] [Abstract] [Full Text] [Related]
17. SETD2 deficiency accelerates mds-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in mds.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
18. Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic Malignancies.
Matesan M; Fisher DR; Wong R; Gopal AK; Green DJ; Sandmaier BM; Bensinger W; Pagel JM; Orozco J; Press OW; Cassaday RD; Hutchinson E; Wanner M; Pal S; Thostenson C; Rajendran JG
J Nucl Med; 2020 Sep; 61(9):1300-1306. PubMed ID: 32169919
[TBL] [Abstract] [Full Text] [Related]
19. Biochemical regulation and structural analysis of copper-transporting ATPase in a human hepatoma cell line for Wilson disease.
Agnihotry S; Dhusia K; Srivastav AK; Upadhyay J; Verma V; Shukla PK; Ramteke PW; Gautam B
J Cell Biochem; 2019 Nov; 120(11):18826-18844. PubMed ID: 31286540
[TBL] [Abstract] [Full Text] [Related]
20. ywhae long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
Bjeije H; Soltani BM; Behmanesh M; Zali MR
Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
[TBL] [Abstract] [Full Text] [Related]
[Next]
